News
Here are a few key lessons any leader can apply when guiding their business through uncertainty or after a reputational hit.
During the fourth quarter, the Harbor Health Care ETF returned –10.89%, underperforming the Russell 3000 Growth Health Care ...
Solid Biosciences is repositioning itself in a scrutinized space with promising early-stage ... which has made investors more skittish across early-stage biotech generally. The market has pulled ...
The three companies—leaders in space systems, biotechnology, and pharmaceutical research—join existing Haven-1 Lab partners Redwire and Yuri, reinforcing Vast’s mission to enable ...
With Haven-1, we aim to redefine what’s possible in biotechnology and pharmaceuticals ... in the specialized development and management of space systems and technology, and has most notably ...
Vast CEO Max Haot, Vast Lead Astronaut Andrew Feustel, Exobiosphere CEO Kyle Acierno, Interstellar Lab CEO Barbara Belvisi, and JAMSS President Teru Aruga (from left to right), standing inside the ...
Exobiosphere, a Luxembourg-based space biotechnology company that develops high-throughput screening platforms to accelerate drug discovery and streamline pre-clinical trial testing. Exobiosphere ...
The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, ...
6d
Zacks Investment Research on MSNShould You Invest in the iShares Biotechnology ETF (IBB)?Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05 ...
The history of biotech is based on building something from nothing and giving the little guy a chance to change the world. This is the perfect space for speculative investors who want to hit stock ...
5d
Axios on MSNChina is beating U.S. in biotech advances, report warnsChina has pulled ahead of the United States in key areas of the life sciences, and the U.S. may only have a handful of years ...
VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results